Osteoporosis and Other Adverse Body Composition Changes during Androgen Deprivation Therapy for Prostate Cancer
- 1 June 2002
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 21 (2) , 159-166
Abstract
Osteoporosis and other body composition changes are important complications of androgen deprivation therapy (ADT) for prostate cancer. Bilateral orchiectomy and gonadotropin-releasing hormone agonist...Keywords
This publication has 46 references indexed in Scilit:
- Low bone mineral density in hormone-na ve men with prostate carcinomaCancer, 2001
- The Use of Biochemical Markers of Bone Turnover in OsteoporosisOsteoporosis International, 2000
- Testosterone Replacement and Resistance Exercise in HIV-Infected Men With Weight Loss and Low Testosterone LevelsJAMA, 2000
- The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinomaCancer, 1998
- Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinomaCancer, 1997
- Testosterone Therapy in Glucocorticoid-Treated MenArchives of internal medicine (1960), 1996
- Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogensCalcified Tissue International, 1995
- The diagnosis of osteoporosisJournal of Bone and Mineral Research, 1994
- Appendicular Bone Density and Age Predict Hip Fracture in WomenJAMA, 1990
- The diagnostic value of bone scintigraphy in patients with low back painSkeletal Radiology, 1983